Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment

Journal of Analytical Toxicology

Volumn 29, Issue 8, 2005, Pages 769-776

  Böttcher, Michael ^a   Beck, Olof ^b  

^a Arztpraxis fur Medizinische Mikrobiologie und Labordiagnostik   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; DIHYDROCODEINE; DRUG METABOLITE; NORBUPRENORPHINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; CLONED ENZYME DONOR IMMUNOASSAY; CROSS REACTION; DILUTION; DRUG DETERMINATION; DRUG SCREENING; DRUG URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEASUREMENT; PRESCRIPTION; QUALITATIVE ANALYSIS; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; SUBSTITUTION THERAPY; URINALYSIS;

EID: 29144519798     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/29.8.769     Document Type: Article

References (28)

1. E.J. Cone and K.L. Preston. Toxicological aspects of heroin substitution treatrment. Ther. Drug Monit. 24: 193-198 (2002).
2. R.P. Mattick, J. Kimber, C. Breen, and M. Davoli. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 4: CD002207 (2003).
3. Y. Obadia, V. Perrin, I. Feroni, D. Vlahov, and J.-P. Moatti. Injecting misuse of buprenorphine among French drug users. Addiction 96: 267-272 (2001).
4. World Health Organization Expert Committee on Drug Dependence. World Health Organ. Tech. Rep. Ser. 915: 1-26 (2003).
5. A. Tracqui, P. Kintz, and B. Ludes. Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities. J. Anal. Toxicol. 22: 430-434 (1998).
6. P. Kintz. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 121: 65-69 (2001).
7. K. Kobayashi, T. Yamamoto, K. Chiba, M. Tani, N. Shimada, T. Ishizaki, and Y. Kuroiwa. Human buprenorphine] N-dealkylation is catalysed by cytochrome P450 3A4. Drug Metab. Dispos. 26: 818-821 (1998).
8. E.J. Cone, C.W. Gorodetzky, D. Yousefnejad, W.F. Buchwald, and R.E. Johnson. The metabolism and excretion of buprenorphine in humans. Drug Metab. Dispos. 12: 577-581 (1984).
9. J.K. Lamba, Y.S. Lin, E.G. Schuetz, and K.E. Thummel. Genetic contribution to variable human CYP3A-mediated metabolism. Adv. Drug Deliv. Rev. 54: 1271-1294 (2002).
10. L. Wojnowski. Genetics of the variable expression of CYP3A in humans. Ther. Drug Monit. 26: 192-199 (2004)
11. C.W. Hand, K.E. Ryan, S.K. Dutt, R.A. Moore, J. O'Connor, D. Talbot, and H.J. McQuay. Radioimmunoassay of buprenorphine in urine: studies in patients and in a drug clinic. J. Anal. Toxicol. 13: 100-104 (1989).
12. D. Martinez, M.C. Jurado, and M. Repetto. Analysis of buprenorphine in plasma and urine by gas chromatography. J Chromatogr. 528: 459-463 (1990).
13. L. Debrabandere, M. Van Boven, and P. Daenens. Development of a radioimmunoassay for the determination of buprenorphine in biological samples. Analyst 118: 137-143 (1993).
14. E. Schleyer, R. Lohmann, C. Rolf, A. Gralow, C.C. Kaufmann, M. Unterhalt, and W. Hiddemann. Column-switching solid-phase trace-enrichment high-performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detection. J. Chromatogr. 614: 275-283 (1993).
15. G. Alemany, A. Gamundi, C. Rossello, and M.C. Nicolau. A simple thin-layer chromatographic method for the analysis of buprenorphine in urine. Biomed. Chromatogr. 10: 146-147 (1996).
16. A. Tracqui, P. Kintz, and P. Mangin. HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples. J. Forensic Sci. 42: 111-114 (1997).
17. A.M. Lisi, R. Kazlauskas, and G.J. Trout. Gas chromatographic-mass spectrometric quantitation of urinary buprenorphine and norbuprenorphine after derivatization by direct extractive alkylation. J. Chromatogr. B 692: 67-77 (1997).
18. F. Vincent, J. Bessard, J. Vacheron, M. Mallaret, and G. Bessard. Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry. J. Anal. Toxicol. 23: 270-279 (1999).
19. V. Cirimele, P. Kintz, S. Lohner, and B. Ludes. Enzyme immunoassay validation for the detection of buprenorphine in urine. J. Anal. Toxicol. 27: 103-105 (2003).
20. R. Kronstrand, T.G. Selden, and M. Josefsson. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry. J. Anal. Toxicol. 27: 464-470 (2003).
21. S. Feng, M.A. ElSohly, and D.T. Duckworth. Hydrolysis of conjugated metabolites of buprenorphine. I. The quantitative enzymatic hydrolysis of buprenorphine-3-β-D-glucuronide in human urine. J. Anal. Toxicol. 25: 589-593 (2001).
22. H. Trauer, H.-J. Wehran, R.K. Müller, and R. Vock. Katalysierte analytische Acetylierung-effizient und schnell. Toxichem. Krimtech. 65: 97 (1998).
23. M. Kolb, A. Bahr, S. Hippich, and W. Schulz. Calculation of detection limit, identification limit and determination limit according to DIN 32645 with the aid of a computer program. Acta Hydrochim. Hydrobiol. 21: 308-311 (1993).
24. S. Iwersen-Bergmann and A. Schmoldt. Direct semiquantitative screening of drugs of abuse in serum and whole blood by means of CEDIA DAU urine immunoassays. J. Anal. Toxicol. 23: 247-256 (1999).
25. R.E. Aderjan and G. Skopp. Formation and clearance of active and inactive metabolites of opiates in humans. Ther. Drug Monit. 20: 561-569 (1998).
26. M. Balikova, V. Maresova, and V. Habrdova. Evaluation of urinary dihydrocodeine excretion in human by gas chromatography-mass spectrometry. J. Chromatogr. B 752: 179-186 (2001).
27. J.J. Kuhlman, Jr., S. Lalani, J. Magluilo, Jr., B. Levine, W.D. Darwin, R.E. Johnson, and E.J. Cone. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J. Anal. Toxicol. 20: 369-378 (1996).
28. S. George, C. George, and M. Chauhan. The development and application of a rapid gas chromatography-mass spectrometry method to monitor buprenorphine withdrawal protocols. Forensic Sci. Int. 143: 121-125 (2004).